Abstract
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have